ur latest in Clinical and Molecular Hepatology is out: “Tracking the trajectory of kidney dysfunction in cirrhosis: the AKI–CKD spectrum.” time to rethink kidney injury as a continuum. pubmed.ncbi.nlm.nih.gov/40138802/
Vishnu Girish
@liveloveliver.bsky.social
Hepatologist | Living the liver life | Advocate for free education | One liver at a time | Celebrating uniqueness, against discrimination #Liversky
A new #PSC review from @f8martine.bsky.social , et al. PSC-IBD is probably a distinct form of IBD with UC and Crohn's. "on a molecular level, almost all people with PSC have underlying colitis" 2024 = 100th anniversary of the description of PSC journals.lww.com/hep/abstract... #liversky
PSC and colitis: A complex relationship : Hepatology
an extraintestinal manifestation of IBD, the clinical phenotype, genetic and intestinal microbiota associations strongly argue for PSC-IBD being a distinct form of IBD, existing alongside ulcerative c...
journals.lww.com
🆕 AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals @amergastroassn.bsky.social #IDsky #Liversky www.gastrojournal.org/action/showP...
Admittedly the cool name of the study group first caught my 👁️ POSEIDON study group showed ✅alfapump 📉need for LVP ✅similar complications ✅improved QOL @amcollegegastro.bsky.social journals.lww.com/ajg/abstract... #liversky
Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...
doi.org
📢Thrilled to share our latest review article. Greatful to Prof. Rakhi Maiwall. We explore challenges of managing septic shock in cirrhosis and advocate for personalized approaches pubmed.ncbi.nlm.nih.gov/39744868/ #liversky #Medsky #GIsky @anandvkulkarni.bsky.social
Great look into the future on HCC surveillance by George Ioannou at AASLD #TLM24 Seems likely that blood based biomarkers and aMRI will play some role but, despite its significant flaws, ultrasound has so far stood the test of time
Did you know... There are nifty one page summaries of selected ACG guidelines available at gi.org/guidelines Just click on the "Summary" tab under the guidelines Here are some examples with many more in development #GISky #LiverSky
